Present status of hemoglobinopathies in India.
Marwaha
R K
RK
Lal
A
A
D000284:Administration, Oral; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D002087:Butyrates / Q000494:pharmacology / Q000627:therapeutic use; D002614:Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects; D015913:Chelation Therapy; D015316:Genetic Therapy; D006801:Humans; D007194:India / Q000453:epidemiology; D017086:beta-Thalassemia / Q000188:drug therapy / Q000453:epidemiology* / Q000235:genetics
D002087:Butyrates; D002614:Chelating Agents; D001120:Arginine; C033018:arginine butyrate